Response to Comment on "Epigenetic activation of the drug transporter OCT2 sensitizes renal cell carcinoma to oxaliplatin".
作者信息
Zheng Xiaoli, Liu Yanqing, Yu Qinqin, Wang Hua, Tan Fuqing, Zhu Qianying, Yuan Lingmin, Jiang Huidi, Zeng Su, Yu Lushan
机构信息
Institute of Drug and Pharmaceutical Analysis, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
Department of Urology, Cancer Hospital of Zhejiang Province, Hangzhou 310022, China.
出版信息
Sci Transl Med. 2017 May 24;9(391). doi: 10.1126/scitranslmed.aam6298.
PMID:28539476
Abstract
摘要
Zotero 插件